Medical technology company Smith & Nephew (SN.L) priced its $700 million offering of 5.75% notes due 2036, according to a Thursday filing.
The proceeds, estimated at $690.9 million, are earmarked to fund the company's tender offer for outstanding 2.032% senior notes due 2030 and for general corporate purposes.
The notes offering is expected to close on Friday.